Biodexa Pharmaceuticals Plc — Form D
Biodexa Pharmaceuticals Plc of CARDIFF, X0, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-04. The offering totals $6.8M, of which $6.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-01-04
- Form: D
- Accession: 0001643918-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.8M
- Amount sold: $6.8M
- Investors: 1
- Date of first sale: 2023-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-501496
Issuer
- Name: Biodexa Pharmaceuticals Plc
- CIK: 0001643918
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Address: 1 CASPIAN POINT, CARDIFF, X0, CF10 4DQ
- Phone: 44 (0)1235 888300
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Dmitry Zamoryakhin | Executive Officer | Cardiff, X0 |
| Stephen Stamp | Director | Cardiff, X0 |
| Stephen Stamp | Executive Officer | Cardiff, X0 |
| Simon Turton | Director | Cardiff, X0 |
| Stephen Parker | Director | Cardiff, X0 |
| Sijmen de Vries | Director | Cardiff, X0 |
| Ann Merchant | Executive Officer | Cardiff, X0 |
| DMITRY B ZAMORYAKHIN | Executive Officer | CARDIFF, X0 |
| STEPHEN B PARKER | Director | CARDIFF, X0 |
| SIJMEN B DE VRIES | Director | CARDIFF, X0 |
| Rolf Stahel | Director | Cardiff, X0 |
| Craig Cook | Director | Cardiff, X0 |
| Craig Cook | Executive Officer | Cardiff, X0 |
| Frederic Duchesne | Director | Cardiff, X0 |
| Huaizheng Peng | Director | Cardiff, X0 |
Other filings by this issuer (5)
More